241 related articles for article (PubMed ID: 27340360)
1. Randomized study of lafutidine vs lansoprazole in patients with mild gastroesophageal reflux disease.
Takenaka R; Okada H; Kawano S; Komazawa Y; Yoshinaga F; Nagata S; Inoue M; Komatsu H; Onogawa S; Kushiyama Y; Mukai S; Todo H; Okanobu H; Manabe N; Tanaka S; Haruma K; Kinoshita Y
World J Gastroenterol; 2016 Jun; 22(23):5430-5. PubMed ID: 27340360
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, controlled study comparing lafutidine with placebo and famotidine in Japanese patients with mild reflux esophagitis.
Ohara S; Haruma K; Kinoshita Y; Kusano M
J Gastroenterol; 2010 Dec; 45(12):1219-27. PubMed ID: 20632193
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.
Kinoshita Y; Miwa H; Sanada K; Miyata K; Haruma K
J Gastroenterol; 2014 Apr; 49(4):628-37. PubMed ID: 23653056
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia.
Maity S; Choudhury S; Hazra A; Das AK
Indian J Pharmacol; 2014; 46(5):498-502. PubMed ID: 25298578
[TBL] [Abstract][Full Text] [Related]
5. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.
Ashida K; Iwakiri K; Hiramatsu N; Sakurai Y; Hori T; Kudou K; Nishimura A; Umegaki E
World J Gastroenterol; 2018 Apr; 24(14):1550-1561. PubMed ID: 29662293
[TBL] [Abstract][Full Text] [Related]
6. Management of symptoms in step-down therapy of gastroesophageal reflux disease.
Mine S; Iida T; Tabata T; Kishikawa H; Tanaka Y
J Gastroenterol Hepatol; 2005 Sep; 20(9):1365-70. PubMed ID: 16105122
[TBL] [Abstract][Full Text] [Related]
7. Observational comparative trial of the efficacy of proton pump inhibitors versus histamine-2 receptor antagonists for uninvestigated dyspepsia.
Nagahara A; Asaoka D; Hojo M; Oguro M; Shimada Y; Ishikawa D; Osada T; Kawabe M; Yoshizawa T; Otaka M; Watanabe S
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S122-8. PubMed ID: 20586853
[TBL] [Abstract][Full Text] [Related]
8. The histamine H2 receptor antagonist lafutidine in Japanese patients with non-erosive reflux disease.
Inamori M; Iida H; Hosono K; Endo H; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Goto A; Abe Y; Hiratsuka N; Nakajima A; Fujita M
Hepatogastroenterology; 2010; 57(104):1430-4. PubMed ID: 21443098
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of host defense mechanism in the suppression of rat acute reflux esophagitis by the particular histamine H2 receptor antagonist lafutidine.
Nakano M; Ajioka H; Abe M; Kiniwa M
Pharmacology; 2012; 90(3-4):205-11. PubMed ID: 23038658
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Lafutidine Versus Famotidine in Patients with Reflux Esophagitis: A Multi-Center, Randomized, Double-Blind, Non-inferiority Phase III Trial.
Kim EH; Lee YC; Chang YW; Park JJ; Chun HJ; Jung HY; Kim HS; Jeong HY; Seol SY; Han SW; Choi MG; Park SH; Lee OJ; Jung JT; Lee DH; Jung HC; Lee ST; Kim JG; Youn SJ; Kim HY; Lee SW
Dig Dis Sci; 2015 Jun; 60(6):1724-32. PubMed ID: 25532503
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux.
Mine S; Fujisaki T; Tabata T; Matsuoka H; Iida T; Yamada S; Tanaka Y; Morimoto I; Eto S; Aibe T
Am J Gastroenterol; 2000 Feb; 95(2):381-6. PubMed ID: 10685739
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy evaluation of lafutidine for mild reflux esophagitis in Japanese patients].
Ohara S; Haruma K; Kinoshita Y; Kusano M
Nihon Shokakibyo Gakkai Zasshi; 2010 Apr; 107(4):588-97. PubMed ID: 20379093
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
[TBL] [Abstract][Full Text] [Related]
14. Improvement in symptoms after H2-receptor antagonist-based therapy for eradication of H pylori infection.
Hagiwara T; Kato M; Anbo T; Imamura A; Suga T; Uchida T; Fujinaga A; Nakagawa M; Nakagawa S; Shimizu Y; Yamamoto J; Takeda H; Asaka M
World J Gastroenterol; 2007 Jul; 13(28):3836-40. PubMed ID: 17657838
[TBL] [Abstract][Full Text] [Related]
15. Lafutidine versus lansoprazole in combination with clarithromycin and amoxicillin for one versus two weeks for Helicobacter pylori eradication in Korea.
Kim N; Park SH; Seo GS; Lee SW; Kim JW; Lee KJ; Shin WC; Kim TN; Park MI; Park JJ; Hong SJ; Shim KN; Kim SW; Shin YW; Chang YW; Chun HJ; Lee OJ; Jeon WJ; Park CG; Cho CM; Park CH; Won SY; Lee GH; Park KS; Shin JE; Kim HU; Park JY; Chae HS; Song GA; Kim JG; Yoon BC; Seol S; Jung HC; Chung IS
Helicobacter; 2008 Dec; 13(6):542-9. PubMed ID: 19166420
[TBL] [Abstract][Full Text] [Related]
16. Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Howden CW; Henning JM; Huang B; Lukasik N; Freston JW
Am J Gastroenterol; 2001 Jun; 96(6):1704-10. PubMed ID: 11419818
[TBL] [Abstract][Full Text] [Related]
17. Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin.
Suzuki T; Kagami T; Uotani T; Yamade M; Hamaya Y; Iwaizumi M; Osawa S; Sugimoto K; Miyajima H; Furuta T
Eur J Clin Pharmacol; 2018 Jan; 74(1):45-52. PubMed ID: 28986609
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease.
Peura DA; Pilmer B; Hunt B; Mody R; Perez MC
Aliment Pharmacol Ther; 2013 Nov; 38(10):1303-11. PubMed ID: 24118079
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial: roxatidine vs omeprazole for non-erosive reflux disease.
Nakamura K; Akiho H; Ochiai T; Motomura Y; Higuchi N; Okamoto R; Matsui N; Yasuda D; Akahoshi K; Kabemura T; Ihara E; Harada N; Ito T; Takayanagi R
Hepatogastroenterology; 2010; 57(99-100):497-500. PubMed ID: 20698216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
